No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
The progress in reperfusion therapy dictated the necessity for developing new tools and procedures for adjacent/additional therapy of acute cardiovascular disorders. The adjacent therapy is targeted on the damage of the microcirculation, leading to the unfavorable prognosis for the patients. The no-...
Saved in:
Main Authors: | Alexander V. Maksimenko, Askar D. Turashev |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Biochemistry Research International |
Online Access: | http://dx.doi.org/10.1155/2012/859231 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dexamethasone Suppressed LPS-Induced Matrix Metalloproteinase and Its Effect on Endothelial Glycocalyx Shedding
by: Na Cui, et al.
Published: (2015-01-01) -
Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
by: Timothy M. Sladden, et al.
Published: (2019-01-01) -
In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
by: Fang Liu, et al.
Published: (2021-01-01) -
A Practical Method for No-Reflow Treatment
by: Mustafa Cetin, et al.
Published: (2016-01-01) -
«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction
by: V.І. Tseluyko, et al.
Published: (2018-09-01)